Here, it was reported that several SNPs in selenoprotein and Se metabolic pathway genes may affect CRC development risk [10], alone or in combination with suboptimal Se status, ascertained by levels of Se and the selenoprotein P (SELENOP) Se transport protein. The gene discussed is SELENOS; the disease is colorectal carcinoma.